Tata Capital, the financial services division of India-based conglomerate Tata, has acquired a minority stake in local healthcare company Marck Biosciences.
The investment is one of the first from the Tata Capital Healthcare Fund I, which made a final close at R320 crore ($40m) in April last year and is run by Visalakshi Chandramouli.
In December, Tata Capital started funding non-emergency hospital costs in partnership with healthcare facilitation and credit analysis company MYA Health Credit.
Tata also has a healthcare-focused private equity partnership with Switzerland-based HBM and has multiple other funds covering minority to majority-stake investments.